[6-K] Inspira Technologies Oxy B.H.N. Ltd. Warrant Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc (LSE/NYSE: HLN) filed a Form 6-K to disclose its share capital position as of 30 June 2025. The Company has issued 8,988,533,553 ordinary shares of £0.01 each, of which 3,880,205 are held in treasury. Consequently, the number of ordinary shares carrying voting rights is 8,984,653,348. This denominator should be used by investors to determine whether their holdings trigger disclosure obligations under the FCA’s Disclosure Guidance and Transparency Rules. No other financial data, corporate actions or strategic updates were included in the filing.

Insights

Financial Analyst

TL;DR: Routine share-count update; no immediate valuation impact, but essential for regulatory threshold calculations.

The 6-K solely updates Haleon’s share count and voting rights. Treasury shares represent roughly 0.04 % of issued stock, leaving an effective float of 8.985 billion shares. Because no buy-back, capital raise, or earnings information is disclosed, the filing is operationally neutral. Nevertheless, accurate denominators are critical for institutional investors monitoring 3 % and 5 % disclosure thresholds under UK and FCA rules. Overall market impact is negligible.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of: July 2025

Commission File Number: 001-40303

Inspira Technologies Oxy B.H.N. Ltd.

(Translation of registrant’s name into English)

2 Ha-Tidhar St.

Ra’anana 4366504, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

On July 1, 2025, Inspira Technologies Oxy B.H.N. Ltd (the “Registrant”) increased the maximum aggregate offering price of its ordinary shares, no par value (the “Ordinary Shares”) issuable under its Sales Agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners, dated March 14, 2025, from $1,917,052 to $7,117,720. A copy of the opinion of Sullivan & Worcester Tel-Aviv (Har-Even& Co.) relating to the legality of the issuance and sale of the Ordinary Shares that may be sold pursuant to the Sales Agreement is attached as Exhibit 5.1 hereto.

This Foreign Private Issuer Report on Form 6-K is incorporated by reference into the Registrant’s Registration Statements on Form F-3 (Registration No. 333-266748 and 333-284308) and Form S-8 (Registration Nos. 333-259057, 333-277980 and 333-285565), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit No.		Description
5.1		Opinion of Sullivan & Worcester Tel-Aviv (Har-Even & Co.)
23.1		Consent of Sullivan & Worcester Tel-Aviv (Har-Even & Co.) (contained in Exhibit 5.1)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Inspira Technologies Oxy B.H.N. Ltd.
Date: July 1, 2025	By:	/s/ Yafit Tehila
		Name:	Yafit Tehila
		Title:	Chief Financial Officer

2

FAQ

How many Haleon (HLN) shares carry voting rights as of 30 June 2025?

Haleon reports 8,984,653,348 ordinary shares with voting rights.

What is Haleon’s total issued share capital reported in the Form 6-K?

Total issued capital is 8,988,533,553 ordinary shares of £0.01 each.

How many treasury shares does Haleon hold?

The company holds 3,880,205 shares in treasury.

Why is the voting-rights figure important for investors?

Investors use it as the denominator to determine when their holdings reach FCA disclosure thresholds.

What type of filing did Haleon submit?

A Form 6-K, providing an update on total voting rights and share capital.